Inhibitory effects of lysozyme on endothelial protein C receptor shedding in vitro and in vivo

BMB Reports

Volumn 48, Issue 11, 2015, Pages 624-629

  Ku, Sae Kwang ^a   Yoon, Eun Kyung ^b   Lee, Hyun Gyu ^c   Han, Min Su ^d   Lee, Taeho ^b   Bae, Jong Sup ^b  

^a Daegu Haany University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Daegu Fatima Hospital   (South Korea)

Author keywords

CLP; EPCR shedding; Lysozyme; Vascular inflammation

Indexed keywords

ACTIVATED PROTEIN C RECEPTOR; BLOOD CLOTTING FACTOR; CELL SURFACE RECEPTOR; INTERLEUKIN 1BETA; LYSOZYME; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR;

ANIMAL; C57BL MOUSE; HUMAN; MALE; METABOLISM; MOUSE; PRIMARY CELL CULTURE;

ANIMALS; BLOOD COAGULATION FACTORS; HUMANS; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MURAMIDASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PRIMARY CELL CULTURE; RECEPTORS, CELL SURFACE; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84943665163     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2015.48.11.038     Document Type: Article

References (35)

1. Esmon CT (2006) The endothelial protein C receptor. Curr Opin Hematol 13, 382-385
2. Fukudome K and Esmon CT (1994) Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269, 26486-26491
3. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL and Esmon CT (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci U S A 93, 10212-10216
4. Mosnier LO, Zlokovic BV and Griffin JH (2007) The cytoprotective protein C pathway. Blood 109, 3161-3172
5. Xu J, Qu D, Esmon NL and Esmon CT (2000) Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem 275, 6038-6044
6. Lee W, Ku SK and Bae JS (2013) Emodin-6-O-beta-D-glucoside down-regulates endothelial protein C receptor shedding. Arch Pharm Res 36, 1160-1165
7. Kurosawa S, Stearns-Kurosawa DJ, Hidari N and Esmon CT (1997) Identification of functional endothelial protein C receptor in human plasma. J Clin Invest 100, 411-418
8. Liaw PC, Neuenschwander PF, Smirnov MD and Esmon CT (2000) Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem 275, 5447-5452
9. Kurosawa S, Stearns-Kurosawa DJ, Carson CW, D'Angelo A, Della Valle P and Esmon CT (1998) Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 91, 725-727
10. Ku SK, Han MS, Lee MY, Lee YM and Bae JS (2014) Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo. BMB Rep 47, 336-341
11. Menschikowski M, Hagelgans A, Eisenhofer G and Siegert G (2009) Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways. Exp Cell Res 315, 2673-2682
12. Han H, Du B, Pan X et al (2010) CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation. Mol Cancer Res 8, 1477-1488
13. Leng Y, Steiler TL and Zierath JR (2004) Effects of insulin, contraction, and phorbol esters on mitogen-activated protein kinase signaling in skeletal muscle from lean and ob/ob mice. Diabetes 53, 1436-1444
14. Huovila AP, Turner AJ, Pelto-Huikko M, Karkkainen I and Ortiz RM (2005) Shedding light on ADAM metalloproteinases. Trends Biochem Sci 30, 413-422
15. Murphy G (2008) The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 8, 929-941
16. Kelly JA, Sielecki AR, Sykes BD, James MN and Phillips DC (1979) X-ray crystallography of the binding of the bacterial cell wall trisaccharide NAM-NAG-NAM to lysozyme. Nature 282, 875-878
17. Clingolani R (2014) Bioinspired approaches for human-centric technologies. Springer, New York
18. Nakimbugwe D, Masschalck B, Deckers D, Callewaert L, Aertsen A and Michiels CW (2006) Cell wall substrate specificity of six different lysozymes and lysozyme inhibitory activity of bacterial extracts. FEMS Microbiol Lett 259, 41-46
19. Borgel D, Bornstain C, Reitsma PH et al (2007) A comparative study of the protein C pathway in septic and nonseptic patients with organ failure. Am J Respir Crit Care Med 176, 878-885
20. Qu D, Wang Y, Song Y, Esmon NL and Esmon CT (2006) The Ser219→Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. J Thromb Haemost 4, 229-235
21. Qu D, Wang Y, Esmon NL and Esmon CT (2007) Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor-alpha converting enzyme/ADAM17. J Thromb Haemost 5, 395-402
22. Michie HR, Manogue KR, Spriggs DR et al (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318, 1481-1486
23. Kremer JP, Jarrar D, Steckholzer U and Ertel W (1996) Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients. Acta Haematol 95, 268-273
24. Buras JA, Holzmann B and Sitkovsky M (2005) Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4, 854-865
25. Yang H, Ochani M, Li J et al (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101, 296-301
26. Bae JS, Lee W, Nam JO, Kim JE, Kim SW and Kim IS (2014) Transforming Growth Factor beta-induced Protein Promotes Severe Vascular Inflammatory Responses. Am J Respir Crit Care Med 189, 779-786
27. Diehl KH, Hull R, Morton D et al (2001) A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21, 15-23
28. Weiler H (2011) Multiple receptor-mediated functions of activated protein C. Hamostaseologie 31, 185-195
29. Wang L, Bastarache JA and Ware LB (2008) The coagulation cascade in sepsis. Curr Pharm Des 14, 1860-1869
30. Sugo T, Nakamikawa C, Tanabe S and Matsuda M (1995) Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets. J Biochem 117, 244-250
31. Thalhamer T, McGrath MA and Harnett MM (2008) MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 47, 409-414
32. Ku SK and Bae JS (2014) Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa/FXa. Arch Pharm Res 37, 1454-1463
33. Miller MA, Meyer AS, Beste MT et al (2013) ADAM-10 and-17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. Proc Natl Acad Sci U S A 110, E2074-2083
34. Bae JS (2011) Antithrombotic and profibrinolytic activities of phloroglucinol. Food Chem Toxicol 49, 1572-1577
35. Kim TH, Ku SK and Bae JS (2012) Antithrombotic and profibrinolytic activities of eckol and dieckol. J Cell Biochem 113, 2877-2883